Open navigation
Search
Offices – Germany
Explore all Offices
Global Reach

Apart from offering expert legal consultancy for local jurisdictions, CMS partners up with you to effectively navigate the complexities of global business and legal environments.

Explore our reach
Search
Expertise
Insights

CMS lawyers can provide future-facing advice for your business across a variety of specialisms and industries, worldwide.

Explore topics
Offices
Global Reach

Apart from offering expert legal consultancy for local jurisdictions, CMS partners up with you to effectively navigate the complexities of global business and legal environments.

Explore our reach
CMS Germany Abroad
Insights
About CMS

Select your region

Deals 17 Mar 2025 · Germany

CMS advises shareholders of zagedo on their sale to Zucchetti

2 min read

On this page

Munich – Creathor Ventures, a leading investor in technology-based companies for the personalisation and digitalisation of healthcare and industrial automation, has sold all of its shares in zagedo GmbH, with its registered office in Innsbruck (Austria), together with the other shareholders.

As part of the transaction, zadego and its German subsidiary were acquired by Zucchetti, a leading European software and technology provider with a strong presence in the hospitality sector. With this acquisition and with the integration of easybooking in the hospitality solution portfolio, Zucchetti expands and further strengthens its position to empower the digitization of small and medium-sized hotels across the DACH region. In return, the acquisition will give zagedo additional resources to further develop its technological excellence and expand its existing customer portfolio of more than 6,000 accommodation providers and hotels in Austria, Germany and Switzerland that already rely on easybooking.

A CMS team headed by partner Dr Michael Wangemann and counsel Dr Christoph Küster provided Creathor Ventures with comprehensive legal advice on the transaction. Creathor Ventures has repeatedly relied on CMS's expertise, most recently in connection with the sale of shares in a provider of technologies for the production of biopharmaceuticals.

The parties have agreed not to disclose the transaction volume.

Press Contact
presse@cms-hs.com

Back to top